版本:
中国

BRIEF-Arrhythmia Research Q4 loss per share $0.11 from continuing operations

March 22 Arrhythmia Research Technology Inc

* Arrhythmia research technology, inc. Reports 2016 fourth quarter and year end results

* Q4 loss per share $0.11 from continuing operations

* Qtrly net sales $ 4.81 million versus $ 4.75 million

* Arrhythmia research technology inc - expect that co's margins will begin to improve during q2 of 2017

* Arrhythmia research technology -"in 2016, revenue and margins in injection molding business steadily increased and we expect this to continue in 2017" Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐